Kaposin and LANA-1 of HHV8 as vaccine targets
HHV8 的卡波辛和 LANA-1 作为疫苗靶标
基本信息
- 批准号:6777003
- 负责人:
- 金额:$ 21.79万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-08-01 至 2006-07-31
- 项目状态:已结题
- 来源:
- 关键词:B lymphocyteHeLa cellsHerpesviridae vaccineKaposi&aposs sarcomaMHC class I antigenantigen antibody reactionbiotechnologycell surface receptorscell transformationcellular immunitychimeric proteinshuman herpesvirus 8humoral immunitylaboratory mouselatent virus infectionneoplasm /cancer immunologyneoplastic processreceptor expressiontissue /cell culturetransfection /expression vectorvaccine developmentvaccinia virusvirus antigenvirus geneticsvirus protein
项目摘要
DESCRIPTION (provided by applicant): Given the oncogenic capabilities of HHV-8, it has been suggested that an understanding of the viral genes with the potential to induce transformation of cells may contribute towards the elucidation of KS pathogenesis. In addition, such genes may also serve as ideal targets for both therapeutic and vaccine interventions. For this purpose, we have considered HHV-8 genes which are expressed during latency, as tumor 'spindle" cells of KS and B-cells are latently infected with HHV-8. Of the genes encoded by HHV-8 with transformation potential [K1, glycoprotein; k9, interferon regulatory factor; K12, kaposin; orf73, latency-associated antigen (LANA-1); and orf74, a vlL-8 receptor homolog ], kaposin and LANA-1 are transcribed in latently infected cells along with v-cyclin and v-FLIP. Both v-cyclin and v-FLIP are viral homologs of cellular genes and thus may not be suitable as targets for vaccine strategies due to autoimmunity. This has prompted us to initiate work on Kaposin and LANA-1 as the likely viral target proteins for vaccine approaches to induce immunity against HHV-8. The recent demonstration of CTL epitopes in Kaposin further lends supports to this concept. Vaccines have been successfully used against viral infections (smallpox, polio, varicella) in the past and the correlates of protective immunity may include both the humoral and cellular responses. Based on this, we hypothesize that the expression of Kaposin and LANA-1, in the absence of other HHV-8 proteins, may lead to an induction of potent and durable humoral and cellular immune responses which may be of value in eliminating cells infected with HHV-8 and interfering with the development of KS. Towards this, we propose the following aims: i) to generate DNA vaccine vectors encoding native and modified forms of Kaposin and LANA-1. ii) Characterize the cellular and humoral immune responses against Kaposin and LANA-1 using mice as the animal model, iii) Strategies to enhance the immune responses against Kaposin, and iv) to assess the level of protection induced by latent genes using tumor cells expressing viral proteins as the challenge model. The results from these studies are likely to provide baseline information for further exploration in the development of vaccines against HHV-8.
描述(由申请方提供):鉴于HHV-8的致癌能力,有人认为了解具有诱导细胞转化潜力的病毒基因可能有助于阐明KS发病机制。此外,这些基因也可以作为治疗和疫苗干预的理想靶点。为此,我们考虑了潜伏期表达的HHV-8基因,因为KS和B细胞的肿瘤“梭形”细胞潜伏感染HHV-8。在由具有转化潜力的HHV-8编码的基因中[K1,糖蛋白; k9,干扰素调节因子; K12,卡泊辛; orf 73,潜伏相关抗原(拉娜-1);和orf 74,vIL-8受体同源物],卡泊辛和拉娜-1与v-细胞周期蛋白和v-FLIP沿着在潜伏感染的细胞中转录。v-cyclin和v-FLIP都是细胞基因的病毒同源物,因此由于自身免疫性,可能不适合作为疫苗策略的靶点。这促使我们开始研究Kaposin和拉娜-1作为疫苗方法诱导抗HHV-8免疫的可能病毒靶蛋白。最近在Kaposin中CTL表位的展示进一步支持了这一概念。过去,疫苗已成功用于对抗病毒感染(天花、脊髓灰质炎、水痘),保护性免疫的相关因素可能包括体液和细胞反应。基于此,我们假设Kaposin和拉娜-1的表达,在没有其他HHV-8蛋白的情况下,可能导致诱导有效和持久的体液和细胞免疫应答,这可能在消除HHV-8感染的细胞和干扰KS的发展方面具有价值。为此,我们提出了以下目标:i)产生编码卡泊辛和拉娜-1的天然和修饰形式的DNA疫苗载体。ii)使用小鼠作为动物模型表征针对Kaposin和拉娜-1的细胞和体液免疫应答,iii)增强针对Kaposin的免疫应答的策略,和iv)使用表达病毒蛋白的肿瘤细胞作为攻击模型评估由潜伏基因诱导的保护水平。这些研究的结果可能为进一步探索HHV-8疫苗的开发提供基线信息。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Alagarsamy Srinivasan其他文献
Alagarsamy Srinivasan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Alagarsamy Srinivasan', 18)}}的其他基金
Kaposin and LANA-1 of HHV8 as vaccine targets
HHV8 的卡波辛和 LANA-1 作为疫苗靶标
- 批准号:
6696091 - 财政年份:2003
- 资助金额:
$ 21.79万 - 项目类别:
相似海外基金
Temporal and spatial localization of TRAPP subunits during the cell cycle of HeLa cells
HeLa 细胞细胞周期中 TRAPP 亚基的时空定位
- 批准号:
432807-2012 - 财政年份:2012
- 资助金额:
$ 21.79万 - 项目类别:
University Undergraduate Student Research Awards
Analysis of the regulation of asymmetric cell division by using the artificially induced polarization of HeLa cells.
利用HeLa细胞的人工诱导极化分析不对称细胞分裂的调控。
- 批准号:
24657088 - 财政年份:2012
- 资助金额:
$ 21.79万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
The internalization mechanism of Ureaplasma parvum in HeLa cells.
小脲原体在 HeLa 细胞中的内化机制。
- 批准号:
23791241 - 财政年份:2011
- 资助金额:
$ 21.79万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
MicroRNA analysis of cervical cancer HeLa cells resistant to gene silencing of human papillomavirus (HPV) E6 and E7 onco
宫颈癌 HeLa 细胞对人乳头瘤病毒 (HPV) E6 和 E7 基因沉默具有抗性的 MicroRNA 分析
- 批准号:
nhmrc : 519809 - 财政年份:2008
- 资助金额:
$ 21.79万 - 项目类别:
Early Career Fellowships
Identification and characterization of new genetic responses in escherichia coli and human (HeLa) cells
大肠杆菌和人类 (HeLa) 细胞中新遗传反应的鉴定和表征
- 批准号:
3222-2002 - 财政年份:2003
- 资助金额:
$ 21.79万 - 项目类别:
Discovery Grants Program - Individual
Identification and characterization of new genetic responses in escherichia coli and human (HeLa) cells
大肠杆菌和人类 (HeLa) 细胞中新遗传反应的鉴定和表征
- 批准号:
3222-2002 - 财政年份:2002
- 资助金额:
$ 21.79万 - 项目类别:
Discovery Grants Program - Individual
Identification and characterization of new genetic responses ub escgerucgua ciku abd gynab (HeLa) cells
新遗传反应 ub escgerucgua ciku abd gynab (HeLa) 细胞的鉴定和表征
- 批准号:
3222-1998 - 财政年份:2001
- 资助金额:
$ 21.79万 - 项目类别:
Discovery Grants Program - Individual
Identification and characterization of new genetic responses ub escgerucgua ciku abd gynab (HeLa) cells
新遗传反应 ub escgerucgua ciku abd gynab (HeLa) 细胞的鉴定和表征
- 批准号:
3222-1998 - 财政年份:2000
- 资助金额:
$ 21.79万 - 项目类别:
Discovery Grants Program - Individual
Identification and characterization of new genetic responses ub escgerucgua ciku abd gynab (HeLa) cells
新遗传反应 ub escgerucgua ciku abd gynab (HeLa) 细胞的鉴定和表征
- 批准号:
3222-1998 - 财政年份:1999
- 资助金额:
$ 21.79万 - 项目类别:
Discovery Grants Program - Individual
Identification and characterization of new genetic responses ub escgerucgua ciku abd gynab (HeLa) cells
新遗传反应 ub escgerucgua ciku abd gynab (HeLa) 细胞的鉴定和表征
- 批准号:
3222-1998 - 财政年份:1998
- 资助金额:
$ 21.79万 - 项目类别:
Discovery Grants Program - Individual